Israel Englander’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-112,600
| Closed | -$9.57K | – | 5848 |
|
|
2020
Q3 | $9.57K | Buy |
112,600
+32,600
| +41% | +$1.65M | 0.01% | 1297 |
|
|
2020
Q2 | $2.83M | Buy |
80,000
+10,000
| +14% | +$292K | ﹤0.01% | 2271 |
|
|
2020
Q1 | $944K | Buy |
+70,000
| New | +$1.18M | ﹤0.01% | 2504 |
|
|
2019
Q2 | – | Sell |
-200,000
| Closed | -$3.84M | – | 4683 |
|
|
2019
Q1 | $3.84M | Sell |
200,000
-30,000
| -13% | -$484K | 0.01% | 1943 |
|
|
2018
Q4 | $3.28M | Buy |
+230,000
| New | +$4.57M | 0.01% | 1872 |
|
|
2018
Q1 | – | Sell |
-90,000
| Closed | -$1.45M | – | 4259 |
|
|
2017
Q4 | $1.45M | Buy |
+90,000
| New | +$1.06M | ﹤0.01% | 2471 |
|
|
2015
Q3 | – | Sell |
-1,200,000
| Closed | -$4.87M | – | 3856 |
|
|
2015
Q2 | $4.87M | Buy |
1,200,000
+700,000
| +140% | +$2.86M | 0.01% | 1416 |
|
|
2015
Q1 | $1.92M | Buy |
+500,000
| New | +$2.17M | ﹤0.01% | 1977 |
|
Israel Englander's IMMU Position: Q4 2020 in Review
Israel Englander sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,750,749 shares — an estimated $234K sold.
Israel Englander first reported a position in IMMU in Q2 2013 and held it in 24 quarters. The position peaked at $102M in Q4 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Israel Englander reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Israel Englander sold 2,750,749 Immunomedics Inc shares in Q4 2020, an estimated $234K.
- Israel Englander first reported a position in Immunomedics Inc in Q2 2013 and held it in 24 quarters.
- Israel Englander's Immunomedics Inc position peaked at $102M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.